Newsroom
The Newsroom section contains information related to health in Alberta – news, facts, publications produced by the ministry, minister speeches and photos gallery, and much more.
This information is intended for all Albertans, including the news media, health professionals and the public.
- Use the links on the left to find the information you need.
Current news
November 20, 2009H1N1 vaccine available to all Albertans over six months of age starting Nov. 23
November 18, 2009
Amendment clarifies sharing of information between ambulance attendants and police
Children and their families next to receive H1N1 vaccine
November 16, 2009
Province’s H1N1 vaccine program expands to more Albertans
November 13, 2009
More highest-risk groups eligible for H1N1 vaccine
November 10, 2009
Targeted H1N1 immunization of priority groups expands
November 6, 2009
Targeted H1N1 immunization of priority groups expands
November 2, 2009
Proposed legislative changes support use of community treatment orders
October 31, 2009
H1N1 clinics suspended due to vaccine supply issues
October 29, 2009
H1N1 vaccine rollout continues
October 23, 2009
Albertans urged to limit consumption of some species of fish
October 21, 2009
Alberta prepared for second wave of H1N1
Current information
Mercury in fish reports
Read the reports and common questions on mercury in fish in Alberta
Alberta Pharmaceutical Strategy
Read the Alberta Pharmaceutical Strategy Phase 2.
Senior Medical Officers of Health
Photos of Medical Officers of Health
Advisory Committee on Health
Minister's Advisory Committee on Health website
Minister's Advisory Committee on Health Terms of Reference 
September 2009
Health Action Plan update
Read the 12-month annual report April 2009
New publicly-funded cancer drug
As of April 1, 2009, the drug Avastin will be added to the list of publicly-funded cancer therapies. Avastin has been successfully used in combination with chemotherapy in the treatment of advanced colorectal cancer.
The Alberta Cancer Board Pharmacy and Therapeutics Committee reviewed their initial 2005 recommendation, and requested in January 2009 that Avastin be added to the cancer drug schedule for advanced colorectal cancer.
